Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB) (FRA:21P), through its wholly-owned subsidiary Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marijuana for Medical Purposes Regulations and operates a 55,200 square foot expandable state-of-the-art production facility in Alberta, Canada. Aurora’s wholly-owned subsidiary, Australis Capital Inc., seeks to be an active participant in the U.S. Cannabis market.